Evidence map›Paper›PMID 42369221›Full record

ArticleSAGE open medicine2026

Factors affecting the survival rate after living donor liver transplantation in the country of Georgia.

Marika Mortuladze, Sophio Beridze, Kakhaber Kashibadze, George Kamkamidze, Lela Shengelia

Abstract read
In one paragraph

Article in SAGE open medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Marika MortuladzeDepartment of Public Health and Evidence-Based Medicine, Batumi Shota Rustaveli State University, Batumi, Georgia.
Sophio BeridzeDepartment of Internal Medicine, Batumi Shota Rustaveli State University, Batumi, Georgia.
Kakhaber KashibadzeDepartment of Surgery, Batumi Shota Rustaveli State University, Batumi, Georgia.
George KamkamidzeDepartment of Public Health and Health Administration, University of Georgia, Tbilisi, Georgia.
Lela ShengeliaDepartment of Public Health and Health Administration, University of Georgia, Tbilisi, Georgia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: We aimed to evaluate factors influencing survival after LDLT in Georgia and to identify underlying causes and strategies for improved outcomes. Methods: A cross-sectional retrospective study including 103 living donor recipients transplanted Results: Overall survival (OS) declined significantly during the first post-transplant year. Kaplan Meier estimated patient survival was 72.8 percent at 1 year, 64.5 percent at 3 years and 63.0 percent at 5 years. The number at risk was 71 at 1 year, 47 at 3 years and 29 at 5 years. Among 103 LDLT recipients, 38 deaths occurred and 65 patients were censored alive during follow up. Median observed follow up was 878 days, IQR 286 to 1989. In the primary Cox proportional hazards model, intra or postoperative complications were associated with higher mortality, adjusted HR 2.67, 95 percent CI 1.38 to 5.16, p = 0.004. HCC was also associated with higher mortality, adjusted HR 3.37, 95 percent CI 1.65 to 6.91, p = <0.001. Schoenfeld residual based tests did not indicate violation of the proportional hazards assumption. Conclusion: This study offers valuable insight into post-transplant LDLT outcomes in Georgia. Identification of key clinical risk factors highlights opportunities for targeted intervention. Given that Georgia's short-term survival rates remain lower than those reported in high-income countries, optimizing modifiable risk factors may improve long-term outcomes.

Indexed as

hepatocellular carcinomaliver transplantationpostoperative complicationsrisk factorssurvival rate

Identifiers

PMID42369221
PMCPMC13305268

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.